Why the study?
Does adherence to pharmacist-driven therapy management improve anticoagulation quality in patients with atrial fibrillation and poor baseline TTR?
Does adherence to pharmacist-driven therapy management improve anticoagulation quality in patients with atrial fibrillation and poor baseline TTR?
Answers are grounded in this paper and cite their sources.
Higher adherence to pharmacist-driven warfarin therapy management significantly improves short- and long-term anticoagulation quality in patients with atrial fibrillation and poor baseline control.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hope et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: